These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26177670)

  • 1. Evaluation of an individual-donation nucleic acid amplification testing algorithm for detecting hepatitis B virus infection in Chinese blood donors.
    Gou H; Pan Y; Ge H; Zheng Y; Wu Y; Zeng J; Yang Z; Pan T; Cun W; Zhou G; Fang G; Zhang J; Zhang K; Zhang R; Sun Y; Xie J; Li J; Wang L
    Transfusion; 2015 Sep; 55(9):2272-81. PubMed ID: 26177670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?
    Stramer SL; Zou S; Notari EP; Foster GA; Krysztof DE; Musavi F; Dodd RY
    Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of hepatitis B virus DNA transcription-mediated amplification testing in hepatitis B surface antigen-positive blood donations.
    Bouchardeau F; Girault A; Razer A; Servant-Delmas A; Mercier M; Laperche S
    Transfusion; 2006 Dec; 46(12):2047-52. PubMed ID: 17176315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrio and Ultrio Plus non-discriminating reactives: false reactives or not?
    Charlewood R; Flanagan P
    Vox Sang; 2013 Jan; 104(1):7-11. PubMed ID: 22765287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood donor screening: how to decrease the risk of transfusion-transmitted hepatitis B virus?
    Niederhauser C; Mansouri Taleghani B; Graziani M; Stolz M; Tinguely C; Schneider P
    Swiss Med Wkly; 2008 Mar; 138(9-10):134-41. PubMed ID: 18330733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of different categories of hepatitis B virus (HBV) infection in a multi-regional study comparing the clinical sensitivity of hepatitis B surface antigen and HBV-DNA testing.
    Lelie N; Bruhn R; Busch M; Vermeulen M; Tsoi WC; Kleinman S;
    Transfusion; 2017 Jan; 57(1):24-35. PubMed ID: 27673757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reassessment of hepatitis B virus window periods for two transcription-mediated amplification assays using screening data of South African blood donors.
    Vermeulen M; van Drimmelen H; Coleman C; Sykes W; Reddy R; Busch M; Kleinman S; Lelie N
    Transfusion; 2019 Sep; 59(9):2922-2930. PubMed ID: 31265759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of individual-donation and minipool nucleic acid amplification test options in detecting window period and occult hepatitis B virus infections.
    Vermeulen M; Coleman C; Mitchel J; Reddy R; van Drimmelen H; Ficket T; Lelie N
    Transfusion; 2013 Oct; 53(10 Pt 2):2459-66. PubMed ID: 23621791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood donor testing for hepatitis B virus in the United States: is there a case for continuation of hepatitis B surface antigen detection?
    Dodd RY; Nguyen ML; Krysztof DE; Notari EP; Stramer SL
    Transfusion; 2018 Sep; 58(9):2166-2170. PubMed ID: 30144082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of individual donor nucleic acid testing (NAT) for the detection of hepatitis B infection by studying diluted NAT yield samples.
    Arora S; Doda V; Kirtania T
    Blood Transfus; 2015 Apr; 13(2):227-32. PubMed ID: 25369612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood donor screening in the Netherlands: Universal anti-HBc screening in combination with HBV nucleic acid amplification testing may allow discontinuation of hepatitis B virus antigen testing.
    van de Laar TJ; Hogema BM; Molenaar-de Backer MW; Marijt-van der Kreek T; Zaaijer HL
    Transfusion; 2021 Jul; 61(7):2116-2124. PubMed ID: 33899233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus nucleic acid testing in Chinese blood donors with normal and elevated alanine aminotransferase.
    Ren FR; Wang JX; Huang Y; Yao FZ; Lv YL; Li JL; Wen GX; Wen XQ; Liu J; Dong XD; Ma HL; Zhou ZM; Bi XH; Tu L; King M; Nelson K; Ness P; Shan H
    Transfusion; 2011 Dec; 51(12):2588-95. PubMed ID: 21682731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the meaning of a nonresolved viral nucleic acid test-reactive minipool?
    Wang L; Chang L; Xie Y; Huang C; Xu L; Qian R; Zhu H; He Y; Li J; Huang H; Li W; Zhang K; Zhang R; Xie J; Sun Y; Li J
    Transfusion; 2015 Feb; 55(2):395-404. PubMed ID: 25125223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-HBc screening - is it worth the effort? Results of a 10-year surveillance programme covering more than 30 million donations in Germany.
    Houareau C; Offergeld R
    Vox Sang; 2019 Jul; 114(5):459-466. PubMed ID: 30968958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of hepatitis B virus infections in blood donors in southern China that are surface antigen positive but nucleic acid testing negative.
    Ye X; Li T; Zhang R; Liu H; Zeng J; Hong W; Lu L; Zhu W; Li S; Xu M; Wu S; Chen L
    Transfusion; 2020 Jul; 60(7):1476-1482. PubMed ID: 32358842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection.
    Kiely P; Margaritis AR; Seed CR; Yang H;
    Transfusion; 2014 Aug; 54(8):2084-91. PubMed ID: 24650170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative hepatitis B virus DNA confirmatory algorithm identified occult hepatitis B virus infection in Chinese blood donors with non-discriminatory nucleic acid testing.
    Deng X; Guo X; Li T; Laperche S; Zang L; Candotti D
    Blood Transfus; 2022 Jan; 20(1):8-17. PubMed ID: 33370226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The yield of universal antibody to hepatitis B core antigen donor screening in the Netherlands, a hepatitis B virus low-endemic country.
    van de Laar TJ; Marijt-van der Kreek T; Molenaar-de Backer MW; Hogema BM; Zaaijer HL
    Transfusion; 2015 Jun; 55(6):1206-13. PubMed ID: 25494685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Frequency Occult Hepatitis B Virus Infection Detected in Non-Resolved Donations Suggests the Requirement of Anti-HBc Test in Blood Donors in Southern China.
    Ye X; Zhao Y; Li R; Li T; Zheng X; Xiong W; Zeng J; Xu M; Chen L
    Front Immunol; 2021; 12():699217. PubMed ID: 34394093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China.
    Ye X; Li T; Xu X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP
    Blood Transfus; 2017 Jan; 15(1):6-12. PubMed ID: 27416568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.